Valiant Organics Limited
NSE: VALIANTORG · Specialty Chemicals · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹2 cr vs borrowings ₹253 cr (FY26): borrowings are higher by ₹251 cr.
- Operating profit covered interest 4.6x in the last 12 months.
- No promoter shares are pledged.
- Operating cash flow was below net profit in 1 of the last 5 years (FY22).
- Net loss in 1 of the last 8 quarters.
- Revenue was higher than a year earlier in 2 of the last 4 quarters.
- Other income was 17% of net profit in the last 12 months.
- Debtor days went from 106 (FY24) to 120 (FY26).
- Dividend paid in 1 of the last 5 financial years.
- Price ₹435.60 on 2026-10-26: -13.7% from the 52-week high, +123.4% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 160 | 187 | 204 | 204 | 157 | 159 | 218 | 232 |
| EBITDA | 2 | 15 | 20 | 25 | 21 | 21 | 26 | 42 |
| OPM % | 1.5% | 8.2% | 10.0% | 12.1% | 13.5% | 13.4% | 12.2% | 18.0% |
| Other income | 3 | 5 | 1 | 1 | 0 | 2 | 4 | 3 |
| Net profit | -13 | 5 | 4 | 8 | 6 | 4 | 16 | 29 |
| EPS (₹) | -4.52 | 1.08 | 1.52 | 2.93 | 2.02 | 1.30 | 5.61 | 10.44 |
| Revenue YoY | -1.8% | -14.8% | +6.9% | +13.3% | ||||
| Profit YoY | – | -33.2% | +274.3% | +254.3% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1,153 | 1,052 | 723 | 719 | 739 | 766 |
| EBITDA | 205 | 169 | 35 | 54 | 94 | 111 |
| Net profit | 113 | 88 | -8 | -4 | 33 | 54 |
| EPS (₹) | 41.72 | 32.45 | -3.07 | -1.24 | 11.86 | 19.37 |
| Revenue growth | -8.8% | -31.3% | -0.6% | +2.8% | +1.4% | |
| Profit growth | -22.2% | -109.5% | – | – | +963.3% | |
| Dividend / share (₹) | – | 4.50 | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -11.1% | – | +1.4% |
| Net profit | -27.7% | – | +963.3% |
| EPS | -28.5% | – | – |
| Share price | – | +1.1% (2y) | +41.0% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 689 | 729 | 725 | 759 |
| Borrowings | – | 274 | 256 | 248 | 253 |
| Cash & equivalents | – | 46 | 7 | 8 | 2 |
| Total assets | – | 1,239 | 1,248 | 1,183 | 1,231 |
| Fixed assets | – | 658 | 630 | 644 | 682 |
| Capital work in progress | – | 71 | 86 | 66 | 21 |
| Investments | – | 4 | 95 | 94 | 151 |
| Receivables | – | 254 | 209 | 177 | 243 |
| Inventory | – | 126 | 114 | 89 | 92 |
| Payables | – | 166 | 207 | 149 | 122 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | -32 | 238 | 84 | 56 | 92 |
| Cash from investing | -122 | -143 | -65 | -21 | -86 |
| Cash from financing | 167 | -112 | -23 | -32 | -11 |
| Capex | 121 | 136 | 74 | 31 | 34 |
| Free cash flow | -153 | 102 | 10 | 26 | 58 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 12.8% | -1.2% | -0.5% | 4.4% |
| ROCE % | – | 15.4% | 0.9% | 2.7% | 6.1% |
| Debtor days | – | 88 | 106 | 90 | 120 |
| Inventory days | – | 67 | 85 | 71 | 76 |
| Payable days | – | 88 | 155 | 119 | 102 |
| Cash conversion cycle (days) | – | 67 | 36 | 42 | 94 |
| Working capital days | – | 27 | 0 | -6 | 1 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 37.89% |
| FIIs | 0.43% |
| DIIs | 0.03% |
| Government | 0.00% |
| Public (non-institutions) | 61.64% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 37.74% | 37.91% | 37.91% | 37.91% | 37.89% | 37.89% | 37.87% | 37.89% |
| Promoter group | % |
|---|---|
| Jaya Chandrakant Gogri | 8.24% |
| Arti Rajendra Gogri | 7.05% |
| Manisha Rashesh Gogri | 5.67% |
| Dilesh Roadlines PVT Ltd | 2.85% |
| Mirik Rajendra Gogri | 2.39% |
| Tulip Family Trust (Gloire Trusteeship Services Private Limited) | 2.18% |
| Ujjwal Business Trust (Alabhya Trusteeship Private Limited) | 2.14% |
| Arvind Kanji Chheda | 1.55% |
| Hiral Arvind Chheda | 1.45% |
| Vicky Hemchand Gala | 0.93% |
| Hetal Gogri Gala | 0.89% |
| Paridhi Business Trust (Saswat Trusteeship Private Limited) | 0.46% |
| Hemchand Lalji Gala | 0.42% |
| Aarti Corporate Services Limited | 0.37% |
| Chandrakant Vallabhaji Gogri | 0.30% |
| Public holders above 1% | % |
|---|---|
| Nikhil Parimal Desai | 9.16% |
| Bhanumati Mohanlal Savla | 3.18% |
| Harsha Mahesh Savadia | 2.30% |
| Bhavesh B Mehta | 2.29% |
| Meena Manoj Chheda | 1.93% |
| Mahesh Mathuradas Savadia | 1.92% |
| Chanchal Devi Lodha | 1.33% |
| Bhavesh Dhirajlal Sheth | 1.21% |
| Nipun Harihar Bhatt | 1.06% |
37,909 shareholders. Pledged: 0.00% of promoter shares.
Peers in Specialty Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,50,431 cr | 56.8x | 13.9x | 25.7% | 33.4% | 24.5% | +7.4% | 1.01% |
| FLUOROCHEM | ₹46,168 cr | 75.4x | 5.9x | 8.1% | 10.0% | 25.6% | -4.2% | 0.07% |
| NAVINFLUOR | ₹39,306 cr | 49.7x | 9.9x | 23.9% | 22.2% | 33.7% | +16.8% | 0.18% |
| DEEPAKNTR | ₹19,676 cr | 25.1x | 3.4x | 14.0% | 15.3% | 15.4% | -0.4% | 0.52% |
| AETHER | ₹19,529 cr | 82.8x | 8.0x | 10.1% | 11.4% | 30.9% | +21.2% | – |
| ATUL | ₹15,762 cr | 19.8x | 2.5x | 11.9% | 16.9% | 17.9% | +7.9% | 0.47% |
| AARTIIND | ₹15,539 cr | 29.3x | 2.6x | 9.2% | 8.0% | 14.9% | +7.8% | 0.24% |
| FINEORG | ₹15,328 cr | 35.0x | 5.8x | 17.7% | 21.3% | 21.7% | -7.8% | 0.22% |
| BASF | ₹13,174 cr | 20.5x | 3.3x | 16.9% | 22.0% | 5.9% | +3.1% | 0.66% |
| VALIANTORG | ₹1,221 cr | 22.5x | 1.6x | 7.3% | 7.8% | 14.4% | -11.1% | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Speciality Chemical Division | ₹575 cr | 77.8% | ₹60 cr | 10.5% |
| Pharma Division | ₹164 cr | 22.2% | ₹-6 cr | -3.6% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2023-02-10 | Dividend | Interim Dividend - Re 1 Per Share |
| 2022-09-20 | Dividend | Dividend - Rs 3.50 Per Share |
| 2020-12-24 | Bonus | Bonus 1:1 |
| 2020-11-24 | Dividend | Interim Dividend - Rs 5 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Manufacturing: Manufacturing and marketing chlorophenols, benzene-based specialty chemicals, and other chemical intermediates
| Sector | Commodities |
| Industry | Specialty Chemicals |
| Sub-industry | Specialty Chemicals |
| Symbol | VALIANTORG |
| BSE code | 540145 |
| ISIN | INE565V01010 |
| Face value | ₹10.0 |
| Incorporated | 2005-02-16 |
| Website | www.valiantorganics.com |
| Plants (India / abroad) | 6 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.